MENU
Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Jul 22, 2019

DaVita's (DVA, $59.31) Q2 operating income outlook comes in higher than expected

Shares of DaVita surged more than +5% in premarket trading Monday, following news of the company’s second-quarter operating income guidance exceeding analysts’ expectations.

The healthcare company reported its projection for second-quarter operating income between $460 million and $465 million - a range that is substantially higher than the FactSet consensus of $398 million. 

For the full-year, the company increased its adjusted operating income guidance to between $1.64 billion and $1.70 billion, from its prior forecast of a range of $1.54 billion to $1.64 billion. 

The news comes ahead of DaVita’s modified Dutch auction tender offer on up to $1.2 billion of its common stock. The auction, priced between $53.50  and $61.50 per share, will start on Monday and continue until August 16 midnight. 

 

 

 

 

Related Ticker: DVA

DVA sees MACD Histogram just turned negative

DVA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on February 07, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on DVA as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

DVA moved below its 50-day moving average on February 14, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DVA advanced for three days, in of 349 cases, the price rose further within the following month. The odds of a continued upward trend are .

DVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 227 cases where DVA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. DVA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.403) is normal, around the industry mean (4.533). P/E Ratio (18.577) is within average values for comparable stocks, (71.885). Projected Growth (PEG Ratio) (1.230) is also within normal values, averaging (1.595). DVA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.026). P/S Ratio (1.058) is also within normal values, averaging (21.325).

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 4.1B. The market cap for tickers in the group ranges from 1.86K to 88.21B. HCA holds the highest valuation in this group at 88.21B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was -2%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was -5%. RHCGF experienced the highest price growth at 30%, while JRSS experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was 28%. For the same stocks of the Industry, the average monthly volume growth was 36% and the average quarterly volume growth was 57%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 57
SMR Rating: 78
Profit Risk Rating: 84
Seasonality Score: -35 (-100 ... +100)
View a ticker or compare two or three
DVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of integrated dialysis services for patients suffering from chronic kidney failure

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
2000 16th Street
Phone
+1 720 631-2100
Employees
70000
Web
https://www.davita.com